Introduction Have you ever wondered how scientists analyze and classify individual cells in seconds? Flow cytometry makes this possible. This powerful technology helps researchers study cellular characteristics and plays a vital role in areas such as cancer research, immunology and microbiology.
Type 1 diabetes (T1D) is a complex autoimmune disease characterized by the immune system’s destruction of insulin-producing β-cells in the pancreas.
In preclinical studies of type 1 diabetes (T1D), accurate measurement of blood glucose levels and assessment of beta-cell mass are critical for understanding disease progression and therapeutic efficacy.
Beta-cell destruction is a defining feature of type 1 diabetes (T1D), where the body’s own immune system selectively targets and destroys insulin-producing cells in the pancreas.
Balancing protection of insulin-producing beta cells with effective immune control remains a core therapeutic challenge in autoimmune diabetes.
Selecting an appropriate type 1 diabetes (T1D) model is critical to generating meaningful and translatable research results.